Breaking news and real-time updates from the ASX small-cap market
Terra Metals extends Southwest strike to 1,350m with a broad high-grade polymetallic reef; maiden MRE slated for Q1 2027 as drilling and metallurgy advance.
Flagship Minerals defines 22–40 Mt tungsten Exploration Target at Khao Soon, Thailand; five zones, 0.15–0.30% WO3. Strategic options: sale, spin-out or JV.
Syntara expands Phase 1b trial for SNT-9465, adding 10 participants, new blinded design and Sydney site; top-line data due Q1 2027 to back an IND.
Industrial Minerals secures North Pool tenement at Laverton, fast-tracking RC drilling to test high-grade hits along the Chatterbox Shear Zone.
LTR Pharma's Spontan intranasal ED spray peaks in 10 minutes, six-fold faster than oral vardenafil; Phase II data complete, paving US licensing talks.
Tartana Minerals kicks off Nightflower drilling, first since 2008, targeting the Digger Lode silver-lead system; rig on site as results shape next phase.
Metallium advances toward commercialisation with a 12-hour FJH chlorination test on PGM feedstock; US govt engagement, mid-2027 revenue potential.
Elixir Energy starts post-soak flow testing at Lorelle-3H; could anchor the Warkon Pilot, with maiden reserves booking hinging on results.
Infragreen Group advances capital management with a $10m on-market buy-back, funded by cash, debt and portfolio cash flow—daily updates.
Vitrafy Life Sciences expands platelet cryopreservation with Versiti; 94.4% post-thaw recovery from USAISR, two free units, US device listing aimed FY2027.
Black Canyon unveils maiden Wandanya MRE: 23.6Mt @ 25.8% Mn (12% cut-off), 3.7Mt DSO at 38.9% Mn; plus 12.5Mt Fe MRE, signaling strong scale and optionality.
Delta Lithium advances Yinnetharra six recon targets in Q4 2026; Mt Ida metallurgical tests progress as cash buffer supports exploration.
